Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms
Cell Commun Signal
The moment you add water, stability drops dramatically
It supports muscle fiber repair, reduces scar tissue formation, and improves oxygen utilization in healing tissue
BPC-157 / TB-500 is a precision co-lyophilized research blend combining two well-characterized peptides in a fixed 1:1 ratio, supplied exclusively for laboratory and preclinical research applications
Our membership reflects our commitment to purity, transparency, and responsible sourcing
